NPI | Name | Type | Address |
---|---|---|---|
DR. PHARMD BCOP Kathryn Ann Culos |
Individual |
1301 Medical Center Dr # 2639 Nashville, TN |
|
PHARMD Shaziya Barkat |
Individual |
1275 York Ave New York, NY |
|
Randa Adib Chaar |
Individual |
55 Park St New Haven, CT |
|
RPH Angela Marie Maroon |
Individual |
3600 N Interstate Ave Portland, OR |
|
PHARMD Rebecca Abramovitz |
Individual |
55 Park St Smilow Oncology Pharmacy New Haven, CT |
|
Arkadiusz W Stobierski |
Individual |
55 Park St New Haven, CT |
|
DR. PHARMD Jessica Noel Leclair |
Individual |
55 Park Street Yale New Haven Hospital New Haven, CT |
|
PHARMD Aubrey Johnson |
Individual |
55 Park St New Haven, CT |
|
PHARMD Katherine Joyce Lin |
Individual |
55 Park St New Haven, CT |
|
Jamie M Blanck |
Individual |
55 Park St New Haven, CT |
|
MR. PHARMD Ibrahim Lala |
Individual |
181 S. Buena Vista St Burbank, CA |
|
MS. PHARM.D. Christine Ibarra |
Individual |
8900 N Kendall Dr Miami, FL |
|
DR. PHARMD Lisa Raff |
Individual |
800 Biesterfield Rd Ste 210 Elk Grove Village, IL |
|
PHARMD Eric James Norman Fela |
Individual |
410 W 10th Ave Columbus, OH |
|
DR. PHARMD Brian Cuong Do |
Individual |
3601 S 6th Ave Tucson, AZ |
|
PHARMD Rebecca Knight |
Individual |
3288 Moanalua Rd Honolulu, HI |
|
PHARMD Kathryn Trieselmann |
Individual |
825 Eastlake Ave E Seattle, WA |
|
PHARM. D Andrea Mcnatty |
Individual |
5881 E Mayo Blvd Phoenix, AZ |
|
PHARMD Lauren Bailey |
Individual |
2525a Holly Hall St Houston, TX |
|
PHARMD Truc Thanh Nguyen |
Individual |
4525 3rd Ave Se Ste 200 Olympia, WA |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |